6.5. 产品管线1 → 6.5.2. 泉生公司一代产品-人自体脂肪干细胞Adipose-derived Stem Cells (ADSC) 制剂 → 6.5.2.0. 立项

一、美国ClinicalTrials.gov信息分析

2021年10月10日美国ClinicalTrials.gov查询显示：全球共有270项Adipose-derived Stem Cells脂肪干细胞的人体临床试验。其中，I期169项；II期167项、III/IV期23项

二、关于人自体脂肪干细胞Adipose-derived Stem Cells (ADSC)是具极重要医疗潜力的干细胞

2019-Adipose Derived Stem Cell-from A Roadmap to Non-Hematopoietic Stem Cell-based Therapeutics, 2019.pdf

2020-Fat Therapeutics The Clinical Capacity of Adipose-Derived Stem Cells and Exosomes for Human Disease and Tissue Regeneration.pdf

2021-Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements- flow chart and regulation updates before and after COVID-19.pdf

2020-Adipose-Derived Stem Cells- Current Applications and Future Directions in the Regeneration of Multiple Tissues.pdf